Pura Vida Investments’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Pura Vida Investments’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-123,416	Closed	-$579K	–	321
2021 Q4	$579K	Sell	123,416 -24,158	-16%	-$150K	0.02%	207
2021 Q3	$912K	Buy	147,574 +50,027	+51%	+$299K	0.03%	226
2021 Q2	$643K	Buy	+97,547	New	+$673K	0.02%	195
2017 Q3	–	Sell	-10,000	Closed	-$222K	–	102
2017 Q2	$222K	Buy	+10,000	New	+$78.7K	0.09%	63

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Pura Vida Investments's AVEO Position: Q1 2022 in Review

Pura Vida Investments sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2022, closing a stake of 123,416 shares — an estimated $579K sold.

Pura Vida Investments first reported a position in AVEO in Q2 2017 and held it in 4 quarters. The position peaked at $912K in Q3 2021. 58 funds tracked by Wall St. Rank hold AVEO as of Q1 2022.

Pura Vida Investments reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Pura Vida Investments sold 123,416 AVEO Pharmaceuticals, Inc. shares in Q1 2022, an estimated $579K.
Pura Vida Investments first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2017 and held it in 4 quarters.
Pura Vida Investments's AVEO Pharmaceuticals, Inc. position peaked at $912K in Q3 2021.
58 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.